The U.S. Department of Justice sought to block the $54 billion combination of two of largest national health insurers. Dylan Carson represented the DOJ in a three-week merger trial in the U.S. District Court for the District of Columbia, prepared an expert economist for testimony and examined an adverse senior executive. The merger was enjoined.
January 2017